Proton therapy in astrocytma was tried in 2012 for the first time.In 2012, Annabelle was diagnosed with fibroblastic astrocytoma, a brain tumor. Surgery removed most of the tumor but unfortunately th...
July 2021: CAR T-Cell therapy in solid tumors has been approved in China with certain indications and markers. Recently, CAR T-Cell therapy is been tested for solid cancers like : Breast cancer ...
Myeloblastoma is one of the most common childhood tumors. Among children under 10 years of age, the incidence rate is about 20% to 30% of all tumors. The peak age of onset is 5 years, and men are slig...
Immunotherapy in treatment of cancerCancer CAR-NK therapy has an effective rate of 73%, and is being recruited in domestic clinical trials.Immunotherapy has revolutionized the way cancer is treated. ...
First immunotherapy has been approved for esophageal cancer treatment. Esophageal cancer is a common malignant tumor. The International Center for Cancer Research of the World Health Organization poi...
Data has proved that there is high cure rate for cervical cancer proton therapy. In daily life, I hear that cervical erosion will become cancerous when it is severe. In fact, not all of them will beco...
Preventing recurrence of lung cancer, preventing recurrence after lung cancer surgery, how to prevent recurrence of lung cancer, how to prevent recurrence of lung cancer. Lung cancer is the l...
89 year old patient who suffers from esophageal cancer and who can't be operated or given chemotherapy fully recovered after proton therapy. Read the full case study over here. Esophag...
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen recepto...
CAR-NK therapy is a new type of immunotherapy in the treatment of cancer treatment. Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divided into two categories: on...